Signal from the log
Primrose Bio
United States
Primrose Bio fabrique les briques de production des biologiques, des vaccins et de l'ARN messager, dont la plateforme d'expression Pfenex. Le tour de croissance est mené par Signet Healthcare Partners, qui entre au conseil. Aucun montant n'est rendu public, donc l'opération reste en réserve.
Spotted Amount read from the headline
Announced on , logged by the watch of 22 September 2026.
- Operation
- Funding round
- Country
- United States
What the log says
Editorial note, in French
Repérée par la collecte. Personne ne l'a encore instruite.
The investors
Led by Signet Healthcare Partners , with 1315 Capital , Ligand Pharmaceuticals , LDV Partners , Agent Capital
What is missing before publishing
- No public amount. A missing amount is never estimated or inferred from a filing.
- The stage of the round is not disclosed. A letter is never inferred from an amount or a track record.
Provenance
Source prnewswire
Logged on 22 September 2026
Description Written in French during the watch run. Written during the watch run, after reading the issuer's press release or the source article.
Verification The fields shown come from an automatic reading of the source headline. They have not yet been checked against the press release and should not be quoted as verified.
What this status means
Spotted The collection saw this operation and logged it. Nobody has processed it yet, so what is shown is still an automatic reading of the source headline.
The rule A signal is never removed from the log. A round set aside stays readable with its reason, because a collection you cannot reread is a collection you cannot correct.